Aayush Food & Herbs Ltd.
Snapshot View

27.35 0.00

09 February 2023, 02:14:00 PM
Volume: 301

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aayushfoods.com
Market Cap 8.88 Cr.
Enterprise Value(EV) 8.01 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -2.44 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share 14.93 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.83 Calculated using Price: 27.35
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.32 Cr. 3,245,000 Shares
FaceValue 10
Company Profile
The company is exporting various varieties of finest rice to many countries with major chunk in parts of West Africa. It is strengthening the distribution network through dealers, agents, companies etc. in home country.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-8.83%
1 Month
+12.55%
3 Month
+33.41%
6 Month
+24.32%
1 Year
+5.80%
2 Year
-13.17%
5 Year
-62.56%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.82 -0.62 2.06 7.68 14.04 11.05 10.26 6.44 -35.95
Return on Capital Employed (%) 0.50 -0.87 2.08 12.11 23.18 20.33 14.99 14.46 -14.90
Return on Assets (%) 0.82 -0.62 1.75 3.05 2.30 1.55 1.52 1.03 -8.75

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 0 4 4 4 5 6 6 7 5 5
Non Curr. Liab. 0 0 0 1 0 1 12 2 5 0
Curr. Liab. 0 1 11 37 29 29 27 1 1
Minority Int.
Equity & Liab. 0 4 6 16 43 35 46 36 11 6
Non Curr. Assets 0 0 0 0 1 1 1 1 0 0
Curr. Assets 0 4 5 16 41 34 45 36 11 5
Misc. Exp. not W/O
Total Assets 0 4 6 16 43 35 46 36 11 6

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 0 0 5 100 188 132 127 152 17 13
Other Income 0 0 0 0 0 1 0 0 1 1
Total Income 0 0 5 100 188 133 127 152 18 14
Total Expenditure 0 0 -5 -100 -187 -132 -126 -150 -19 -14
PBIDT 0 0 0 1 1 1 2 2 -1 0
Interest 0 0 0 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 1 1 1 0 -2 -1
Adjusted EPS 0 0 0 1 2 2 2 1 -6 -2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 -4 0 -1 6 -3 -10 6 -3
Cash Fr. Inv. 0 -1 0 0 0 0
Cash Fr. Finan. 0 4 1 -1 1 11 -9 3
Net Change 0 0 0 0 4 -2 1 -3 1
Cash & Cash Eqvt 0 0 0 0 5 3 3 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.28 51.28 51.28 32.52 32.52 32.52 32.52 32.52 32.52
Public 48.72 48.72 48.72 67.48 67.48 67.48 67.48 67.48 67.48
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 08 Feb 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vinit Kumar Gupta
Wed, 08 Feb 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Classic Mercantile LLP
Mon, 06 Feb 2023
Board Meeting Intimation for The Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2022
Aayush Food And Herbs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31 2022. Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Monday February 13 2023 at the Registered Office of the Company situated at 370-A/2 First Floor Chirag Delhi New Delhi- 110017 inter-alia to consider and approve Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31 2022.

Technical Scans View Details >>

Wed, 08 Feb 2023
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
High Increase in 1 Month High Increase in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.40 -0.6%
Cipla Ltd. 83,886.47 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,503.40 +0.4%
Divi's Laboratories Ltd. 74,340.49 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,541.95 -0.9%
Zydus Lifesciences Ltd. 47,993.66 473.85 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.85 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.85 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.85 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.85 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.85 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.85 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,022.55 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,503.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,814.60 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.75 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.85 0.0%

FAQ's On Aayush Food & Herbs Ltd.

What is Aayush Food share price?

Can I buy Aayush Food shares now?

What is the Market Cap of Aayush Food?

What are the key metrics to analyse Aayush Food?

What is the 52 Week High and Low of Aayush Food?

What is the trend of Aayush Food share price?